Schunn, Fabian A. http://orcid.org/0000-0001-5598-7461
El Shafie, Rami A.
Kronsteiner, Dorothea
Sauer, Lukas D.
Kudak, Andreas
Bougatf, Nina
Oetzel, Dieter
Krämer, Anna
Regnery, Sebastian
Machmer, Timo
Debus, Jürgen
Nicolay, Nils Henrik
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 2 June 2023
Accepted: 1 October 2023
First Online: 10 November 2023
Conflict of interest
: R.A. El Shafie reports personal fees from Accuray, AstraZeneca, BMS, Novocure, Merck, Takeda, and grants from Accuray outside the submitted work. J. Debus received grants from CRI—The Clinical Research Institute GmbH, View Ray Inc., Accuray International, Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Merck Serono GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix A.A., and IntraOP Medical outside the submitted work. N.H. Nicolay received speaker honoraria from Merck and research grants from Novocure outside of the submitted work. F.A. Schunn, D. Kronsteiner, L.D. Sauer, A. Kudak, N. Bougatf, D. Oetzel, A. Krämer, S. Regnery, and T. Machmer declare that they have no competing interests.